Pharmafile Logo
Pharmafocus logo
Advanced Search
lilly2_web

Lilly gets second shot at application for ‘blockbuster’ arthritis drug

August 31, 2017
Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical

Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …

News
teva

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017
Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …

News
novartis_hq_day

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …

News
2000px-flag_of_south_korea

J&J offers $134,000 grant to find the best start-up in South Korea

August 31, 2017
Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …

News

Abbott issues patch for vulnerable heart devices

August 31, 2017
Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …

News
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …

Appointment
shutterstock_212035546

Immunotherapy firm develops breakthrough method for robust bispecific antibody production

August 30, 2017
Research and Development antibodies, immunotherapy, merus, pharma, pharmaceuticals

A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …

News
fda_building_web

FDA approves first treatment for the ‘silent killer’

August 30, 2017
Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …

News
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017
Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

News
ecstasy_monogram

FDA fast-tracks recreational drug MDMA for treatment of PTSD

August 30, 2017
Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …

News
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News
astrazeneca_logo_building

AstraZeneca unloads another drug for $400m

August 29, 2017
Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …

News

Novartis names new Chief Digital Officer

August 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Appointment
adults-1853851_960_720

Thyroid disorders: An illness underestimated

August 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …

Feature
800px-cancer_cells_1

New research reports first-ever response of central nervous tumour to CAR T therapy

August 29, 2017
Manufacturing and Production, Research and Development CAR T, CAR-T, Cancer, life sciences, lymphoma, medicine, pharma, pharmaceuticals

Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …

News

Novartis’ drug prevents heart attacks and cancer but faces major challenges

August 29, 2017
Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical

It would be expected that when a company releases data to show that its drug, previously only used in a …

News
merckincweb

MSD scores trial success in reducing cardiovascular risk

August 29, 2017
Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …

News
gilead-sciences

Gilead captures Kite in $11.9bn deal

August 29, 2017
Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical

Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …

News
astrazeneca-sign

AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site

August 29, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

News
glass-1206584_960_720

Lithium levels in water supply could prevent dementia

August 25, 2017
Research and Development biotech, drugs, lithium, pharma, pharmaceutical

Lithium has long been used in the treatment of people living with bipolar disorder and animal studies have found potential …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026